Gerdau S.A. (GGB)
NYSE: GGB · Real-Time Price · USD
2.960
-0.050 (-1.66%)
Jul 31, 2025, 4:00 PM - Market closed

Orchard Therapeutics Analyst Ratings

Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$3.80
Upside
+28.38%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Strong Buy
Upgrades
$2.9$3.8
Strong BuyUpgrades$2.9$3.8+28.38%Jun 9, 2025
UBS
UBS
Hold
Maintains
$3.3$2.9
HoldMaintains$3.3$2.9-2.03%Apr 30, 2025
UBS
UBS
Hold
Initiates
n/a
HoldInitiatesn/an/aMar 12, 2025
B of A Securities
B of A Securities
Strong Buy
Upgrades
$4.5$5
Strong BuyUpgrades$4.5$5+68.92%May 24, 2024
JP Morgan
JP Morgan
Buy
Upgrades
$4.17$5
BuyUpgrades$4.17$5+68.92%Apr 15, 2024
B of A Securities
B of A Securities
Hold
Downgrades
$4.67$4.25
HoldDowngrades$4.67$4.25+43.58%Nov 20, 2023
JP Morgan
JP Morgan
Hold
Downgrades
$5.56$4.76
HoldDowngrades$5.56$4.76+60.81%Feb 9, 2023
Credit Suisse
Credit Suisse
Buy
Upgrades
n/a
BuyUpgradesn/an/aSep 9, 2021
JP Morgan
JP Morgan
Buy
Upgrades
n/a
BuyUpgradesn/an/aSep 1, 2017
Credit Suisse
Credit Suisse
Buy
Upgrades
n/a
BuyUpgradesn/an/aAug 4, 2016
JP Morgan
JP Morgan
Hold
Downgrades
n/a
HoldDowngradesn/an/aJul 10, 2014
JP Morgan
JP Morgan
Buy
Upgrades
n/a
BuyUpgradesn/an/aMar 14, 2014
JP Morgan
JP Morgan
Hold
Downgrades
n/a
HoldDowngradesn/an/aMay 24, 2013
JP Morgan
JP Morgan
Buy
Upgrades
n/a
BuyUpgradesn/an/aFeb 22, 2013